在急性淋巴细胞白血病中使用CRISPR/Cas9调解向基因编辑的治疗应用:当前前景,未来的挑战和临床影响
Alan Jhones Barbosa Assis1, Brunna Letícia de Oliveira Santana1, Ana Cristina Moura Gualberto1
1Laboratory of Molecular Pathology of Cancer, Faculty of Health Sciences and Medicine, University of Brasília, Brasília, Brazil.
Frontiers in pharmacology
|December 22, 2023
概括
CRISPR/Cas9基因编辑提供了针对急性淋巴细胞白血病 (ALL) 遗传变化的新方法. 这项技术有助于开发改进的疗法,克服耐药性,并推进儿童白血病的CAR-T细胞免疫疗法.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因编辑技术 基因编辑技术
背景情况:
- 急性淋巴细胞白血病 (ALL) 是一种常见的儿科血液恶性瘤,具有显著的分子和临床异质性.
- 遗传和获得的遗传变化在ALL病变发生过程中起着至关重要的作用,破坏了细胞的基本功能.
- 了解这些分子基础是推进ALL治疗策略的关键.
研究的目的:
- 审查CRISPR/Cas9基因编辑在确定ALL治疗点中的应用.
- 探索CRISPR/Cas9如何帮助克服ALL治疗中的耐药性.
- 检查CRISPR/Cas9在推进儿童ALLCAR-T细胞免疫治疗中的作用.
主要方法:
- 文献综述侧重于CRISPR/Cas9在急性淋巴细胞白血病研究中的应用.
- 对研究CRISPR/Cas9用于ALL的标识别和验证的研究进行分析.
- 对CRISPR/Cas9在增强ALLCAR-T细胞治疗中的作用的研究评估.
主要成果:
- 克里斯普尔/Cas9促进了对ALL发育至关重要的特定基因组标的识别.
- 基因编辑工具显示出绕过ALL药物耐药性机制的潜力.
- 克里斯普尔/卡斯9在优化CAR-T细胞治疗中发挥了重要作用,以提高ALL的疗效.
结论:
- 克里斯普尔/Cas9是一种强大的工具,用于剖析ALL病原体,并确定新的治疗策略.
- 应用CRISPR/Cas9对改善治疗结果和克服儿科ALL的耐药性具有显著的前景.
- 对CRISPR/Cas9应用的进一步研究至关重要,以充分发挥其在ALL治疗和免疫治疗中的潜力.
相关概念视频
CRISPR
51.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.4K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
Homologous Recombination
50.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


